Neuroendoscopy Market Share

Neuroendoscopy Market Overview 

The Neuroendoscopy Market is anticipated to reach USD 0.33 Billion by 2032 at 5.2% CAGR during the forecast period 2023-2032. Neuroendoscopy is a minimally invasive surgical treatment for the removal of tumors that is widely used. The excision is done through small pores in the skull, such as the mouth or nose. A compact telescopic gadget with a high-resolution video camera and an eyepiece is used in neuro endoscopy operations. This allows neurosurgeons to traverse and effectively access areas of the brain that are not accessible through standard surgery. Fast healing, little scarring, and other benefits of neuro endoscopy are only a few. The rising occurrence of brain tumors is a primary driver of market expansion for neuroendoscopy. Neuroendoscopy is a procedure in which a neurosurgeon uses an endoscope to traverse and access a tumor. Neurosurgeons attach specific devices to the endoscope, frequently an extra endoscope with forceps and scissors on the end, to remove a tumor or take a sample of it (a biopsy), as opposed to traditional open brain surgery, which takes longer to heal and causes less discomfort. Patients also experience minimal scarring as a result of neuroendoscopic operations. These advantages are well recognized in the medical profession, and as a result, these operations are becoming more widespread around the world. As a result, the advantages of neuroendoscopic surgery over traditional brain surgery are projected to propel the industry forward.

Figure 1- Global Neuroendoscopy Market Share, by Region

 

Sources: WHO, Indian Brand Equity Foundation, Neuro-Oncology, Cancer Research UK, National Institute of Health, annual reports, press release, white paper, and company presentation

Neuroendoscopy Market Segmentation

The global market for neuroendoscopy is segmented on the basis of product, application, usability, and end-user.

On the basis of products, the global market of neuroendoscopy is segmented into rigid neuroendoscopes and flexible neuroendoscopes. The rigid neuroendoscopes segment is sub-segmented into rigid video scopes and rigid fiberscopes. On the basis of application, the market for neuroendoscopy is categorized into transnasal neuroendoscopy, intraventricular neuroendoscopy, and transcranial neuro-endoscopy. On the basis of usability, the neuroendoscopy market is segmented into reusable neuroendoscopes and disposable neuroendoscopes. On the basis of end-users, the market is segmented into hospitals, clinics, medical research centers, and others.

Neuroendoscopy Market Regional Analysis

The Americas dominates the global market of neuroendoscopy. Factors such as the increasing prevalence of brain tumors, the presence of a well-developed healthcare sector, and huge health care expenditures within the region drive the market growth within the region. Moreover, the presence of key players such as Stryker and Medtronic, besides others and the growing geriatric population within the region fuel the market growth.

Europe stands second in the neuroendoscopy market due to the increasing demand for minimally invasive surgeries, rising availability of funds for research and development, and a huge patient population. According to the Cancer Research U.K., the total number of new cases for brain tumor was estimated to be about 11,432 in 2015.  

Followed by Europe, Asia Pacific stands third in the market of neuroendoscopy. Moreover, the region is projected to be the fastest growing region in the global market. This can be attributed to the presence of developing economies such as China, growing patient population, developing healthcare sector, and increasing per capita healthcare expenditures. Additionally, favorable government policies support the market growth. Medical tourism and rising geriatric population are estimated to fuel the market growth. According to the Indian Brand Equity Foundation, the medical tourism industry in India is estimated to grow rapidly and reach USD 9 billion by 2020.

The Middle East and Africa holds the least market share in the global market of neuroendoscopy due to the presence of poor economies, stringent government policies, lack of awareness, low per capita income, and poor availability of healthcare services, especially within the African region. A majority of the neuroendoscopy market within the region is held by the Middle East due to the presence of a well-developed healthcare sector and huge healthcare expenditure.Recent Development

ClearPoint Neuro Inc., a global therapy-enabling platform firm that provides brain navigation and delivery, announced a strategic and commercial cooperation with Adeor Medical AG, a German surgical equipment provider, in August 2021.

In 2017, KARL STORZ teamed with Ortega Clinic in Peru to provide an integrated KARL STORZ 3D operating room (OR) and accessories to the facility. B.Braun also established a subsidiary in Zambia in 2017. This will assist the organization in establishing its business in Zambia and expanding its presence throughout Africa.Neuroendoscopy Market Key players

The key players in the global neuroendoscopy market are KARL STORZ (Germany), B. Braun (Germany), Ackermann Instrumente (Germany), Adeor Medical (Germany), Hangzhou Hawk Optical Electronic Instruments (China), Machida Endoscope (Japan), Tonglu Wanhe Medical Instrument (China), Schindler Endoskopie (Germany), Clarus Medical (U.S.), LocaMed (U.K), Visionsense Corporation (U.S.), Olympus Corporation (Japan), Zeiss International (Germany), Stryker (U.S.), Medtronic (U.S.), and others.

Intended Audience

• Pharmaceutical Companies


• Biotechnological Institutes


• Government and Private Laboratories


• Research and Development (R&D) Companies


• Medical Research Laboratories


• Market Research and Consulting Service Providers

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report